Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 895

Sort by

Sort Order Select

Journal Articles

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model

Manuel J. Feinauer, Stefan W. Schneider, Anna S. Berghoff, Jose Ramon Robador, Cedric Tehranian, Matthia A. Karreman, Varun Venkataramani, Gergely Solecki, Julia Katharina Grosch, Katharina Gunkel, Bogdana Kovalchuk, Frank Thomas Mayer, Manuel Fischer, Michael O. Breckwoldt, Maik Brune, Yannick Schwab, Wolfgang Wick, Alexander T. Bauer, Frank Winkler

Blood (2021) 137 (9): 1219–1232.

https://doi.org/10.1182/blood.2020005710

Published: 2021

Includes: Supplemental data

Journal Articles

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Frits I. Mulder, Floris T. M. Bosch, Annie M. Young, Andrea Marshall, Robert D. McBane, II, Tyler J. Zemla, Marc Carrier, Pieter Willem Kamphuisen, Patrick M. M. Bossuyt, Harry R. Büller, Jeffrey I. Weitz, Saskia Middeldorp, Nick van Es

Blood (2020) 136 (12): 1433–1441.

https://doi.org/10.1182/blood.2020005819

Published: 2020

Includes: Supplemental data

Journal Articles

Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?

Marc Carrier, Tzu-Fei Wang

Blood (2020) 136 (6): 669–673.

https://doi.org/10.1182/blood.2019004177

Published: 2020

Journal Articles

Acute treatment of venous thromboembolism

Cecilia Becattini, Giancarlo Agnelli

Blood (2020) 135 (5): 305–316.

https://doi.org/10.1182/blood.2019001881

Published: 2020

Journal Articles

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Bart J. Biemond, MD PhD, Anil Tombak, MD, Yurdanur Kilinc, MD, Murtadha Al-Khabori, MD, Miguel R. Abboud, MD, Mohammed Nafea, MD, Adlette Inati, MD, Yasser Ahmed Mohamed Soliman Wali, MD, Jens Kristensen, MD PhD, Ellen Donnelly, PhD, John Ohd, MD PhD

Blood (2019) 134 (Supplement_1): 614.

https://doi.org/10.1182/blood-2019-124653

Published: 2019

Journal Articles

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Andrew B Wilks, MD MS, Daniel Douce, MD, Steven Ades, MD, Mary Cushman, MD MSc, Neil A. Zakai, MD MSc, Chris E. Holmes, MD PhD

Blood (2019) 134 (Supplement_1): 709.

https://doi.org/10.1182/blood-2019-128831

Published: 2019

Journal Articles

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Guy Meyer, Celine Chapelle, Philippe Girard, MD, Florian Scotté, MD PhD, Anne Lamblin, Silvy Laporte, MS, PhD

Blood (2019) 134 (Supplement_1): 167.

https://doi.org/10.1182/blood-2019-129087

Published: 2019

Journal Articles

Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study

Damon E. Houghton, MDMS, Henny Heisler H. Billett, MD, Manila Gaddh, MD, Oluwatomiloba Onadeko, MBBS, Gemlyn George, MD, Tzu-Fei Wang, MD MPH, Thein H. Oo, MD, Yuanyue Sun, MD, Mingen Feng, MS, Michael Jaglal, MD, Michael B. Streiff, MD, Pippa Simpson, PhD, Radhika Gali, MD, Lisa Baumann Kreuziger, MD MS

Blood (2019) 134 (Supplement_1): 325.

https://doi.org/10.1182/blood-2019-124139

Published: 2019

Journal Articles

Low Molecular Weight Heparin Vs Direct Oral Anticoagulants (Apixaban, Edoxaban and Rivaroxaban) for the Treatment of Cancer Associated Thrombosis: A Cost- Effective Analysis

Shuchi Gulati, MD, Zizi Elsisi, Smruti Deoghare, Mark Eckman

Blood (2019) 134 (Supplement_1): 328.

https://doi.org/10.1182/blood-2019-124756

Published: 2019

Journal Articles

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Miriam Kimpton, MD, Srishti Kumar, MSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD, Kednapa Thavorn, MPharm, PhD

Blood (2019) 134 (Supplement_1): 329.

https://doi.org/10.1182/blood-2019-127286

Published: 2019

Journal Articles

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Alexander T Cohen, MBBS, MSc, MD, Allison Keshishian, Theodore Lee, MD, Gail Wygant, RN, MS, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Daniel Wiederkehr, MPH, Janvi Sah, MS, Xuemei Luo, PhD

Blood (2019) 134 (Supplement_1): 326.

https://doi.org/10.1182/blood-2019-121769

Published: 2019

Journal Articles

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Blood (2019) 134 (Supplement_1): 327.

https://doi.org/10.1182/blood-2019-126931

Published: 2019

Journal Articles

Direct Oral Anticoagulants Compared to Low Molecular Weight Heparin in the Treatment of Cancer-Associated Thromboembolism: An Updated Meta-Analysis of Randomized Controlled Trails

Sariya Wongsaengsak, MD, Somedeb Ball, MD, Nuvneet Khandelwal, MD, Alay Tikue, MD, Arunee Motes, Nusrat Jahan, MD, Kyaw Zin Thein, MDMBBS, Lukman Tijani, MD

Blood (2019) 134 (Supplement_1): 4962.

https://doi.org/10.1182/blood-2019-125473

Published: 2019

Journal Articles

Comparison of Two Different ELISA Methods for Heparin-Induced Thrombocytopenia (HIT) Screening on an Automated ELISA Platform

Tatsiana Mardovina, MD PhD, John G Chromczak, MLS(ASCP)cmSHcm, Paul W Riley, PhD MBA

Blood (2019) 134 (Supplement_1): 4935.

https://doi.org/10.1182/blood-2019-125293

Published: 2019

Journal Articles

The Safety of Novel Drugs Targeting Factor XI and XII in Human Clinical Trials:a Systematic Review

Gillian E Mair, Sven Reid Olson, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 4966.

https://doi.org/10.1182/blood-2019-130823

Published: 2019

Journal Articles

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Marianne Sinn, Christiane Pollich, Hanno Riess, Sven Bischoff, Piet Habbel, Christian W Scholz, Ernst Spaeth-Schwalbe, Maike de Wit, Anja Jühling, Eike Wolter, Lilianna Wislocka, Dr. Klamroth

Blood (2019) 134 (Supplement_1): 4969.

https://doi.org/10.1182/blood-2019-128166

Published: 2019

Journal Articles

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

Beverly Schaefer, MD, Adriane Hausfeld, Paul Steele, MD, Jan Martin, Sandra Brannon, Adam Lane, PhD, Lori Luchtman-Jones, MD

Blood (2019) 134 (Supplement_1): 4915.

https://doi.org/10.1182/blood-2019-123716

Published: 2019

Journal Articles

VTE Incidence in RRMM Patients Treated with NOVEL Agents: A Monocentric Real Life Experience

Gaetano Giuffrida, MD, Concetta Conticello, MD, Valeria Calafiore, Enrica Antonia Martino, MD, Silvia Giamporcaro, MD, Alessandra Romano, MD PhD, Francesco Di Raimondo, MD

Blood (2019) 134 (Supplement_1): 4972.

https://doi.org/10.1182/blood-2019-131015

Published: 2019

Journal Articles

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Salma Shivji, MDFRCPC, Philip Chiang, MBSc, Lana A Castellucci, MD FRCPC, MSc, Elianna Saidenberg, MD FRCPC

Blood (2019) 134 (Supplement_1): 4974.

https://doi.org/10.1182/blood-2019-128395

Published: 2019

Journal Articles

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Ismail Elalamy, MD PhD

Blood (2019) 134 (Supplement_1): 4979.

https://doi.org/10.1182/blood-2019-123031

Published: 2019

NARROW

Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?

Acute treatment of venous thromboembolism

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis Prevention

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Optimal Timing for Removal of an Upper Extremity Central Catheter When Associated with a Deep Vein Thrombosis: A Venous Thromboembolism Network US Multicenter Retrospective Cohort Study

Low Molecular Weight Heparin Vs Direct Oral Anticoagulants (Apixaban, Edoxaban and Rivaroxaban) for the Treatment of Cancer Associated Thrombosis: A Cost- Effective Analysis

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Direct Oral Anticoagulants Compared to Low Molecular Weight Heparin in the Treatment of Cancer-Associated Thromboembolism: An Updated Meta-Analysis of Randomized Controlled Trails

Comparison of Two Different ELISA Methods for Heparin-Induced Thrombocytopenia (HIT) Screening on an Automated ELISA Platform

The Safety of Novel Drugs Targeting Factor XI and XII in Human Clinical Trials:a Systematic Review

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Comparison of Low Molecular Weight Heparin Activity Assays with and without Addition of Exogenous Antithrombin in a Pediatric and Young Adult Leukemia Cohort

VTE Incidence in RRMM Patients Treated with NOVEL Agents: A Monocentric Real Life Experience

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only